Security key
14147L108
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 32,345,011
- Total 13F value
- $101,559,895
- Share change
- +3,983,664
- Put/Call ratio
- 26%
- SEC-reported price per share
- $3.14
- Number of holders
- 116
- Value change
- +$10,196,300
- Number of buys
- 65
- Number of sells
- 33
- Shares outstanding
- 66,404,538
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
116
Top holders
10
CRDF full security history
Ownership snapshot
Full 13F holder table
Cardiff Oncology, Inc. SEC filings
Cardiff Oncology, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of CRDF - Cardiff Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PFIZER INC
Disclosed value leader
Commodore Capital LP
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
13D/G
Lead comparable stake: 3.6%
13D/G row: PFIZER INC
Showing 1-6 of 15 holder rows.
Quick read
PFIZER INC leads the comparable SEC ownership view at 3.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PFIZER INC's linked filing trail.
Comparable ownership
Top 5
PFIZER INC
3.6%
Commodore Capital LP
8.1%
BlackRock, Inc.
4.3%
VANGUARD GROUP INC
3.4%
ORBIMED ADVISORS LLC
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PFIZER INC |
13F
13D/G
Company · Pfizer Inc. 13-5315170
|
3.6%
from 13D/G
|
$10,466,236
2,411,575 shares
|
— | 31 Dec 2024 |
| Commodore Capital LP |
13F
Company
|
8.1%
|
$23,369,233
5,384,616 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
4.3%
|
$12,329,545
2,840,909 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.4%
|
$9,916,539
2,284,917 shares
|
— | 31 Dec 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
2.3%
|
$6,676,925
1,538,462 shares
|
— | 31 Dec 2024 |
| ACORN CAPITAL ADVISORS, LLC |
13F
Company
|
2.2%
|
$6,259,617
1,442,308 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
116
Shares
32,345,011
Rows available
116
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
116
Q1 2025 holders
116
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|